This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regents of the University of Minnesota. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yungfang Li: Innovator in Chimeric IgG Fc Receptor Treatments
Introduction
Yungfang Li is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical treatments, particularly through his innovative work on chimeric IgG Fc receptors.
Latest Patents
Yungfang Li holds a patent for "Treatments Administering Chimeric IgG Fc Receptor Comprising an Extracellular Domain of CD64." This patent reflects his dedication to advancing therapeutic options in immunology.
Career Highlights
Li is affiliated with the Regents of the University of Minnesota, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on treatment methodologies.
Collaborations
Throughout his career, Yungfang Li has collaborated with esteemed colleagues such as Jianming Wu and Bruce Kenneth Walcheck. These partnerships have further enriched his research endeavors.
Conclusion
Yungfang Li's contributions to the field of medical treatments through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in immunological therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile